The PI3K-Akt-mTOR pathway is upregulated in AML cells, potentially contributing to metabolic reprogramming, e.g., constitutively active mutant Akt seems to display increased glycolysis [76]. This evidence concerns the gene AKT1 and acute myeloid leukemia.